Question

Which of the following is a key feature of the gene therapy Casgevy, recently approved by the U.S. FDA for sickle cell disease?

Q: Answer-Which of the following is a key feature of the gene therapy Casgevy, recently approved by the U.S. F...

The correct answer is A. Casgevy, one of the U.S. FDA-approved gene therapies for sickle cell disease, utilizes CRISPR gene editing technology. This advanced genetic editing approach is notable for its precision and was awarded the Nobel Prize in 2020.